Physician profile
Jana Tomsky
NPI 1346308798
$1,725.97
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2020: $806.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $343.56 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $276.13 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.52 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $145.03 | 2019 | |
| Novo Nordisk INC | $112.98 | 2019-2020 | |
| Amarin Pharma, INC. | $92.64 | 2020 | |
| Allergan, INC. | $77.23 | 2020 | |
| Lilly USA, LLC | $75.72 | 2019-2020 | |
| Bausch Health US, LLC | $75.30 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.43 | 2019-2020 | |
| Antares Pharma, INC. | $45.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $42.67 | 2019-2020 | |
| Radius Health, INC. | $38.46 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $32.50 | 2019-2020 | |
| Astellas Pharma US INC | $31.91 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.58 | 2020 | |
| Cranial Technologies, INC | $20.66 | 2020 | |
| Sanofi-Aventis U.S. LLC | $18.65 | 2019 | |
| Hologic Sales and Service, LLC | $17.94 | 2019 | |
| Amgen INC. | $17.25 | 2019 | |
| Eisai INC. | $15.65 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jana Tomsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.